Biogen Inc. (BIIB)
NASDAQ: BIIB · Real-Time Price · USD
121.80
-1.73 (-1.40%)
May 5, 2025, 4:00 PM EDT - Market closed
Biogen Stock Forecast
Stock Price Forecast
The 23 analysts with 12-month price forecasts for Biogen stock have an average target of 202.91, with a low estimate of 115 and a high estimate of 340. The average target predicts an increase of 66.59% from the current stock price of 121.80.
Analyst Consensus: Buy
Analyst Ratings
The average analyst rating for Biogen stock from 27 stock analysts is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Dec '24 | Jan '25 | Feb '25 | Mar '25 | Apr '25 | May '25 |
|---|---|---|---|---|---|---|
| Strong Buy | 6 | 6 | 7 | 7 | 7 | 6 |
| Buy | 7 | 6 | 6 | 6 | 6 | 6 |
| Hold | 13 | 14 | 14 | 14 | 15 | 15 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 26 | 26 | 27 | 27 | 28 | 27 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| JP Morgan | JP Morgan | Hold Maintains $185 → $175 | Hold | Maintains | $185 → $175 | +43.68% | May 5, 2025 |
| RBC Capital | RBC Capital | Buy Maintains $217 → $205 | Buy | Maintains | $217 → $205 | +68.31% | May 2, 2025 |
| Canaccord Genuity | Canaccord Genuity | Strong Buy Maintains $265 → $220 | Strong Buy | Maintains | $265 → $220 | +80.62% | May 2, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $241 → $187 | Strong Buy | Maintains | $241 → $187 | +53.53% | May 2, 2025 |
| Baird | Baird | Buy Maintains $300 → $255 | Buy | Maintains | $300 → $255 | +109.36% | May 2, 2025 |
Financial Forecast
Revenue This Year
9.41B
from 9.68B
Decreased by -2.78%
Revenue Next Year
9.33B
from 9.41B
Decreased by -0.78%
EPS This Year
16.08
from 11.18
Increased by 43.86%
EPS Next Year
16.21
from 16.08
Increased by 0.76%
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 10.4B | 10.8B | 12.0B | ||
| Avg | 9.4B | 9.3B | 9.5B | ||
| Low | 8.7B | 8.4B | 8.6B |
Revenue Growth
| Revenue Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 7.7% | 15.3% | 29.0% | ||
| Avg | -2.8% | -0.8% | 2.1% | ||
| Low | -9.8% | -10.4% | -7.9% |
EPS Forecast
| EPS | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 21.15 | 21.68 | 26.79 | ||
| Avg | 16.08 | 16.21 | 17.47 | ||
| Low | 13.80 | 11.96 | 13.16 |
EPS Growth
| EPS Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 89.2% | 34.8% | 65.3% | ||
| Avg | 43.9% | 0.8% | 7.8% | ||
| Low | 23.4% | -25.6% | -18.8% |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.